Skip to main content

Table 2 Formulations of Aβ11 delivery systems with different molar ratios

From: Dual-targeting tigecycline nanoparticles for treating intracranial infections caused by multidrug-resistant Acinetobacter baumannii

 

CSs

1%Aβ11

5%Aβ11

10%Aβ11

PLS100

60

60

60

60

Chol

30

30

30

30

PEG2000-Chol

10

9

5

0

Aβ11-PEG2000-Chol

0

1

5

10